Processing and Presentation of Ectromelia Virus to CD4+ T Lymphocytes
异常鼠病毒向 CD4 T 淋巴细胞的加工和呈递
基本信息
- 批准号:7746211
- 负责人:
- 金额:$ 35.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAntigen Presentation PathwayAntigen-Presenting CellsAntigensAntiviral AgentsAutomobile DrivingBiochemicalBiological AssayCD4 Positive T LymphocytesCellsClassificationCommitComplementComplexDataEpitopesEvolutionFutureGenerationsHistocompatibility Antigens Class IIImageImmuneImmune responseImmune systemImmunityImmunologic MemoryIn VitroInbred BALB C MiceInfectionInfectious AgentInfectious EctromeliaLibrariesMHC Class II GenesMapsMeasuresModelingMonkeypoxMouse Pox VirusMusPathway interactionsPeptidesPhasePhenotypePlayPopulationPoxviridaePredispositionProcessProductionPropertyProteinsPublishingRecyclingRelative (related person)ResearchResistanceRiskRoleSmallpoxSpecificityStagingStudy modelsSystemTestingTherapeuticTimeVaccine DesignVacciniaVaccinia Virus StudyVaccinia virusVirusVirus DiseasesWorkantigen processingbiodefensein vivoinhibitor/antagonistinsightmulticatalytic endopeptidase complexpathogenprogramsresponsesynthetic peptide
项目摘要
Project 3 is motivated by two concepts. First, CD4+ T lymphocytes (TCD4+), which recognize virus-derived
peptides in the context of MHC class II molecules, are vital to the host in driving and potentiating adaptive
responses and establishing immunological memory. Second, the interplay between pathogens and their
natural hosts is exquisitely complex and experimental systems in which the virus and host have not
coevolved risk missing crucial insights into these relationships. Despite this, there have been few studies of
TCD4+ responses to a natural infection. Ectromelia virus, (ECTV) the mouse poxvirus, provides this
opportunity in a highly relevant model featuring a broad range of susceptibilities. Though closely related, the
much studied vaccinia virus (VACV) is not a mouse pathogen and preliminary results from all three labs have
identified many fundamental differences between responses to ECTV and VACV. Thus, we expect that a
systematic examination of the TCD4+ response to ECTV vs. VACV in resistant and susceptible mice will
reveal insights with broad relevance. This highly integrated project has four independent but thematically
connected aims. Aim 1 will define the peptide targets of TCD4+ responses, identify the processing pathways
responsible for their generation, and ask whether peptide identity dictates TCD4+ phenotype. This work will
be complemented in Aim 2 by imaging studies which will identify the relevant antigen presenting cells in vivo,
determine how different types of antigen are presented in vivo, and examine the dynamics of TCD4+
activation following infection. In the third aim we will assess the role in protective immunity of peptides
generated by a nonclassical but prevalent cytosolic processing pathway. Finally, published and preliminary
data indicate that VACV interferes with class ll-restricted peptide presentation. In aim 4, we will assess the
degree to which ECTV is committed to this endeavor. In addition to providing valuable information about the
roles of TCD4+ in a natural infection, results from Project 3 integrate with those of the highly complementary
Projects 1 and 2 to form a comprehensive picture of the ECTV/mouse dynamic. This picture will not only
provide future directions for the program, but also insights into many other virus/host relationships.
项目3由两个概念驱动。首先,CD 4 + T淋巴细胞(TCD 4+),它识别病毒衍生的
在MHC II类分子的背景下,肽对宿主在驱动和增强适应性免疫中至关重要。
反应和建立免疫记忆。第二,病原体与它们之间的相互作用
自然宿主是非常复杂的实验系统,在这些系统中,病毒和宿主都没有
共同进化的风险错过了对这些关系的关键见解。尽管如此,很少有研究表明
TCD 4+对自然感染的反应。鼠痘病毒(ECTV)提供了这种
在一个高度相关的模式,具有广泛的资格的机会。虽然关系密切,
许多研究牛痘病毒(VACV)不是小鼠病原体,所有三个实验室的初步结果表明,
发现了ECTV和VACV反应之间的许多根本差异。因此,我们预计,
在抗性和易感小鼠中系统检查TCD 4+对ECTV与VACV的反应,
揭示具有广泛相关性的见解。这个高度综合的项目有四个独立的,但主题
连接的目标。目的1:确定TCD 4+应答的肽靶点,确定TCD 4+应答的加工途径
负责它们的产生,并询问肽身份是否决定了TCD 4+表型。这项工作将
在目标2中通过成像研究来补充,成像研究将在体内鉴定相关的抗原呈递细胞,
确定不同类型的抗原如何在体内呈递,并检查TCD 4+的动态
感染后激活。在第三个目标中,我们将评估肽在保护性免疫中的作用。
由非经典但普遍的胞质加工途径产生。最后,已公布和初步
数据表明VACV干扰II类限制性肽呈递。在目标4中,我们将评估
ECTV致力于这一奋进的程度。除了提供有关
TCD 4+在自然感染中的作用,项目3的结果与高度互补的
项目1和2形成了一个全面的图片ECTV/鼠标动态。这张照片不仅
为该计划提供了未来的方向,但也深入了解了许多其他病毒/宿主关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laurence Crane Eisenlohr其他文献
Laurence Crane Eisenlohr的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laurence Crane Eisenlohr', 18)}}的其他基金
Targeting of RAG-dependent and -independent innate immune responses by the Ectromelia C15 protein
Ectromelia C15 蛋白靶向 RAG 依赖性和非依赖性先天免疫反应
- 批准号:
10364738 - 财政年份:2021
- 资助金额:
$ 35.16万 - 项目类别:
Targeting of RAG-dependent and -independent innate immune responses by the Ectromelia C15 protein
Ectromelia C15 蛋白靶向 RAG 依赖性和非依赖性先天免疫反应
- 批准号:
10205831 - 财政年份:2021
- 资助金额:
$ 35.16万 - 项目类别:
Delineating the non-conventional MHC class I and class II peptidome of influenza
描述流感的非传统 MHC I 类和 II 类肽组
- 批准号:
10041955 - 财政年份:2020
- 资助金额:
$ 35.16万 - 项目类别:
Delineating the non-conventional MHC class I and class II peptidome of influenza
描述流感的非传统 MHC I 类和 II 类肽组
- 批准号:
10171775 - 财政年份:2020
- 资助金额:
$ 35.16万 - 项目类别:
Defining the MHC-II processing and presentation landscape of HIV-1
定义 HIV-1 的 MHC-II 处理和表达景观
- 批准号:
9762836 - 财政年份:2018
- 资助金额:
$ 35.16万 - 项目类别:
MHCII Cross-presentation as a Driver of CD4+ T Cell Responses to Poxviruses
MHCII 交叉呈递作为 CD4 T 细胞对痘病毒反应的驱动因素
- 批准号:
9198974 - 财政年份:2015
- 资助金额:
$ 35.16万 - 项目类别:
MHCII Cross-presentation as a Driver of CD4+ T Cell Responses to Poxviruses
MHCII 交叉呈递作为 CD4 T 细胞对痘病毒反应的驱动因素
- 批准号:
9108850 - 财政年份:2015
- 资助金额:
$ 35.16万 - 项目类别:
Alternative MHCII Processing of Influenza Virus Proteins
流感病毒蛋白的替代 MHCII 加工
- 批准号:
8764161 - 财政年份:2014
- 资助金额:
$ 35.16万 - 项目类别:
Class II Processing and Presentation During Secondary Responses to Influenza
流感二次反应期间的 II 类处理和呈现
- 批准号:
8823195 - 财政年份:2014
- 资助金额:
$ 35.16万 - 项目类别:
Alternative MHCII Processing of Influenza Virus Proteins
流感病毒蛋白的替代 MHCII 加工
- 批准号:
9061590 - 财政年份:2014
- 资助金额:
$ 35.16万 - 项目类别:
相似海外基金
RNA vaccine that exerts antitumor effect via non-canonical antigen presentation pathway
通过非经典抗原呈递途径发挥抗肿瘤作用的RNA疫苗
- 批准号:
19K07782 - 财政年份:2019
- 资助金额:
$ 35.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Climate change and fish disease: In vivo and in vitro studies of the modulation of the teleost antigen presentation pathway in response to thermal stress and viral infection using two different system
气候变化和鱼类疾病:使用两种不同的系统对硬骨鱼抗原呈递途径的调节响应热应激和病毒感染进行体内和体外研究
- 批准号:
469000-2014 - 财政年份:2015
- 资助金额:
$ 35.16万 - 项目类别:
Banting Postdoctoral Fellowships Tri-council
Climate change and fish disease: In vivo and in vitro studies of the modulation of the teleost antigen presentation pathway in response to thermal stress and viral infection using two different system
气候变化和鱼类疾病:使用两种不同的系统对硬骨鱼抗原呈递途径的调节响应热应激和病毒感染进行体内和体外研究
- 批准号:
469000-2014 - 财政年份:2014
- 资助金额:
$ 35.16万 - 项目类别:
Banting Postdoctoral Fellowships Tri-council
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
- 批准号:
8652945 - 财政年份:2012
- 资助金额:
$ 35.16万 - 项目类别:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
- 批准号:
8466919 - 财政年份:2012
- 资助金额:
$ 35.16万 - 项目类别:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
- 批准号:
9054767 - 财政年份:2012
- 资助金额:
$ 35.16万 - 项目类别:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
单纯疱疹病毒-1逃避CD1d抗原呈递途径
- 批准号:
8373738 - 财政年份:2012
- 资助金额:
$ 35.16万 - 项目类别:
Investigation of the HLA class II Antigen Presentation Pathway in Estrogen Receptor Negative and Estrogen Receptor Positive Breast Carcinoma.
雌激素受体阴性和雌激素受体阳性乳腺癌中 HLA II 类抗原呈递途径的研究。
- 批准号:
186899 - 财政年份:2009
- 资助金额:
$ 35.16万 - 项目类别:
Fellowship Programs
Down regulation of antigen presentation pathway plays an important role in metastasis and progression of advanced stage of epithelial ovarian cancer.
抗原呈递途径的下调在上皮性卵巢癌晚期的转移和进展中发挥重要作用。
- 批准号:
21390449 - 财政年份:2009
- 资助金额:
$ 35.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New anti-tuberculosis vaccine strategies by the use of the CD1-lipid antigen presentation pathway
利用 CD1-脂质抗原呈递途径的新抗结核疫苗策略
- 批准号:
15390317 - 财政年份:2003
- 资助金额:
$ 35.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




